These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22768660)

  • 1. Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns.
    Ryckman KK; Cook DE; Berberich SL; Shchelochkov OA; Berends SK; Busch T; Dagle JM; Murray JC
    J Pediatr Endocrinol Metab; 2012; 25(3-4):301-5. PubMed ID: 22768660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
    Zhang Q; Wang B; Chen Y; Jiang D; Chen Y
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):706-9. PubMed ID: 25476436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
    Gatelais F; Berthelot J; Beringue F; Descamps P; Bonneau D; Limal JM; Coutant R
    Pediatr Res; 2004 Nov; 56(5):701-5. PubMed ID: 15371568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE; Moon Y; Lee MH; Jun YH; Oh KI; Choi JW
    Ann Clin Lab Sci; 2008; 38(3):235-40. PubMed ID: 18715851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants.
    Nordenström A; Wedell A; Hagenfeldt L; Marcus C; Larsson A
    Pediatrics; 2001 Oct; 108(4):E68. PubMed ID: 11581476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia.
    Cavarzere P; Samara-Boustani D; Flechtner I; Dechaux M; Elie C; Tardy V; Morel Y; Polak M
    Eur J Endocrinol; 2009 Aug; 161(2):285-92. PubMed ID: 19451212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.
    Pearce M; Dauerer E; DiRienzo AG; Caggana M; Tavakoli NP
    Eur J Pediatr; 2017 Jan; 176(1):121-129. PubMed ID: 27900477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17-hydroxiprogesterone values in healthy preterm infants.
    Mendoza-Rojas VC; Díaz-Martínez LA; Mantilla-Mora G; Contreras-García GA; Mora-Bautista VM; Martínez-Paredes JF; Calderón-Rojas AL; Gómez-Tarazona CA; Pinzón-Mantilla K
    Colomb Med (Cali); 2017 Dec; 48(4):161-166. PubMed ID: 29662257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal corticosteroids and newborn screening for congenital adrenal hyperplasia.
    King JL; Naber JM; Hopkin RJ; Repaske DR; Bailey L; Leslie ND
    Arch Pediatr Adolesc Med; 2001 Sep; 155(9):1038-42. PubMed ID: 11529806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
    Anandi VS; Shaila B
    J Pediatr Endocrinol Metab; 2017 May; 30(6):677-681. PubMed ID: 28489558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N; Peter M; Sander S; Steuerwald U; Terhardt M; Holtkamp U; Sander J
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2581-9. PubMed ID: 17456574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of a precursor-to-product ratio in the evaluation of presumptive positives in newborn screening of congenital adrenal hyperplasia.
    Tieh PY; Yee JK; Hicks RA; Mao CS; Lee WN
    J Perinatol; 2017 Mar; 37(3):283-287. PubMed ID: 27929529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P; Camilot M; Teofoli F; Tatò L
    Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
    Yoon YA; Woo S; Kim MS; Kim B; Choi YJ
    Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):216-221. PubMed ID: 36854385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE; Tetlow L; Tobi S; Patel L; Clayton PE
    Arch Dis Child; 2014 Feb; 99(2):158-64. PubMed ID: 24225272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission.
    Pauwels G; Allegaert K; Régal L; Meulemans A
    Acta Clin Belg; 2012; 67(2):88-93. PubMed ID: 22712163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY; Park HD; Kim JW; Oh HJ; Yang JS; Chang YS; Park WS; Lee SY
    J Perinat Med; 2014 Jan; 42(1):121-7. PubMed ID: 23989111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.